Sasha Stafford Professional Experience
Sasha is a senior translational scientist and consultant dedicated to moving medical breakthroughs from the lab to patients. He specializes in biomaterials and drug delivery.
Wyss Institute at Harvard
Leading efforts to translate complex drug delivery technologies into clinical use. He manages high-level collaborations between academic researchers and major industry partners.
PRESENT ROLE
Consultant & Researcher
A proven leader in CMC and QMS, Sasha ensures technologies meet ICH and FDA standards. He mentors teams to bridge the gap between scientific discovery and regulated production.
KEY EXPERTISE
Healthcare Expert
Expertise in building therapeutic systems that satisfy global regulatory bodies. He works with biotech and pharma leaders to create scalable solutions that improve patient compliance and reduce suffering.
CORE CAREER
Alexander (Sasha) Stafford is a premier translational scientist at Harvard’s Wyss Institute, specializing in the commercialization of complex healthcare innovations. By integrating deep expertise in bioengineering with a strategic financial lens, he transforms laboratory breakthroughs into clinical-grade assets for oncology and immunology.
With a decade of leadership across the pharma and biotech sectors, Sasha provides the technical and strategic oversight necessary to move emerging technologies toward clinical reality. He is an expert in navigating the transition from discovery to scalable production, having successfully led IND-enabling CMC programs, authored foundational patents, and secured significant venture and non-dilutive funding.
Sasha’s value lies in his ability to de-risk development through rigorous analytical validation and regulatory alignment. His comprehensive experience includes managing cGMP-compliant operations, overseeing international CMO partnerships, and ensuring platforms meet stringent ICH and FDA standards. He acts as a critical bridge between academic discovery and industrial application, ensuring that scientific rigor and commercial viability go hand-in-hand.
As a consultant, Sasha empowers cross-functional teams to solve high-stakes drug delivery challenges. His focus is on creating sophisticated biomaterial systems and delivery vehicles that are not only scientifically sound but also designed for patient compliance. By streamlining complex delivery methods, Sasha helps his clients improve therapeutic efficacy and achieve superior patient outcomes on a global scale.
Drug Delivery & Biomaterials
Hydrogels and cryogels; click‑crosslinked alginates; injectable scaffolds; lipid nanoparticles (LNPs); liposomes and micelles; virosomes; PLGA microparticles and scaffolds; mRNA and nucleic‑acid delivery; vaccine depots and combination products.
Regulatory & Translational
ICH/FDA‑aligned method qualification (e.g., ICH Q2(R1)), CMC support for IND submissions, quality management systems, SOP and documentation systems, audit preparation and defense, tech transfer to industry, oversight of CMOs and CROs, safety and compliance programs.
Skills and Expertise
Analytical & Quality
HPLC (reverse‑phase, SEC, GPC, IEC, HILIC, chiral), ELISA, capillary electrophoresis, PAGE and Western blot, IEF, FTIR, rheology, dynamic light scattering, microscopy, flow cytometry, spectroscopic assays, dissolution and stability testing, clinical kit and final product configuration. cGMP laboratory operations, assay development and remediation, method qualification and validation, QC release and stability programs.
Leadership & Collaboration
Team leadership and mentoring of scientists, research associates, and students; cross‑functional project management; interface with clinical, QA, and development teams; industry‑academic partnerships; sponsored research agreements; presentations at scientific meetings and consortia.